{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:07:39Z","timestamp":1791389259827,"version":"4.3.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41390-025-03941-1","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:16:26Z","timestamp":1740410186000},"page":"1209-1211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dupilumab successfully controlled eczema in Wiskott-Aldrich Syndrome over 52 weeks"],"prefix":"10.1038","volume":"98","author":[{"given":"Changhua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"3941_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1586\/1744666X.2015.1062366","volume":"11","author":"AJJ Worth","year":"2015","unstructured":"Worth, A. J. J. & Thrasher, A. J. Current and emerging treatment options for Wiskott-Aldrich Syndrome. Expert Rev. Clin. Immunol. 11, 1015\u20131032 (2015).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"3941_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.817427","volume":"13","author":"KE Herman","year":"2022","unstructured":"Herman, K. E. et al. Il-17-dependent dysregulated cutaneous immune homeostasis in the absence of the Wiskott-Aldrich Syndrome protein. Front. Immunol. 13, 817427 (2022).","journal-title":"Front. Immunol."},{"key":"3941_CR3","doi-asserted-by":"publisher","first-page":"e13951","DOI":"10.1111\/pai.13951","volume":"34","author":"RC Vieira","year":"2023","unstructured":"Vieira, R. C., Pinho, L. G. & Westerberg, L. S. Understanding immunoactinopathies: a decade of research on Was Gene defects. Pediatr. Allergy Immunol. 34, e13951 (2023).","journal-title":"Pediatr. Allergy Immunol."},{"key":"3941_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/cpdd.780","volume":"9","author":"P Kovalenko","year":"2020","unstructured":"Kovalenko, P. et al. Base and covariate population pharmacokinetic analyses of dupilumab using phase 3 data. Clin. Pharm. Drug Dev. 9, 756\u2013767 (2020).","journal-title":"Clin. Pharm. Drug Dev."},{"key":"3941_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10875-021-01157-6","volume":"42","author":"G Consiglieri","year":"2022","unstructured":"Consiglieri, G., Ferrua, F., Aiuti, A. & Cicalese, M. P. A case of two adult brothers with Wiskott-Aldrich Syndrome, one treated with gene therapy and one with HLA-identical hematopoietic stem cell transplantation. J. Clin. Immunol. 42, 421\u2013425 (2022).","journal-title":"J. Clin. Immunol."},{"key":"3941_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07125-8","volume":"7","author":"P Kalailingam","year":"2017","unstructured":"Kalailingam, P. et al. Conditional knock out of N-Wasp in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation. Sci. Rep. 7, 7311 (2017).","journal-title":"Sci. Rep."},{"key":"3941_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","volume":"143","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky, E. et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J. Allergy Clin. Immunol. 143, 155\u2013172 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"3941_CR8","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1111\/all.15432","volume":"77","author":"E Berdyshev","year":"2022","unstructured":"Berdyshev, E. et al. Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis. Allergy 77, 3388\u20133397 (2022).","journal-title":"Allergy"},{"key":"3941_CR9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s10875-023-01525-4","volume":"43","author":"D Adir","year":"2023","unstructured":"Adir, D., Freund, T., Dotan, A., Mashiah, J. & Hagin, D. Dupilumab for post-hematopoietic cell transplantation dermatitis in Wiskott-Aldrich Syndrome. J. Clin. Immunol. 43, 1526\u20131528 (2023).","journal-title":"J. Clin. Immunol."},{"key":"3941_CR10","doi-asserted-by":"crossref","unstructured":"Alzahrani, F., Miller, H. K., Sacco, K. & Dupuy, E. Severe eczema in Wiskott-Aldrich Syndrome-related disorder successfully treated with dupilumab. Pediatr. Dermatol. 41, 143\u2013144 (2023).","DOI":"10.1111\/pde.15397"},{"key":"3941_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaad.2024.05.029","volume":"91","author":"T-L Lin","year":"2024","unstructured":"Lin, T.-L. et al. Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: a population-based cohort study. J. Am. Acad. Dermatol. 91, 466\u2013473 (2024).","journal-title":"J. Am. Acad. Dermatol."},{"key":"3941_CR12","doi-asserted-by":"crossref","unstructured":"Callewaert, C. et al. Il-4r\u03b1 blockade by dupilumab decreases staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis. J. Investig. Dermatol. 140, 191\u2013202.e7 (2020).","DOI":"10.1016\/j.jid.2019.05.024"},{"key":"3941_CR13","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jaip.2023.03.020","volume":"11","author":"DYM Leung","year":"2023","unstructured":"Leung, D. Y. M. et al. Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin. J. Allergy Clin. Immunol. Pract. 11, 1421\u20131428 (2023).","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03941-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T19:02:26Z","timestamp":1761246146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03941-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-03941-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The patient gave consent for his photographs and medical information to be published in print and online and with the understanding that this information may be publicly available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}